EXELTIS
Lupin gets USFDA nod for generic oral contraceptive pillLupin has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Drosp...
Stocks in the news: Lupin, BHEL, Canara Bank, RBL Bank, L&T and PNBKotak Mahindra Bank, L&T, Vedanta, Britannia, Dr Reddy's Labs, Marico, Info Edge, Bharat Electronics, Au SFB and Oberoi Realty are among th...
Lupin partners with Exeltis for marketing its specialty drug Solosec in USET reported in October about Lupin trying to find a marketing partner or even be open to the idea of possible sale of its key specialty dru...
Lupin inks distribution pact with 3 firms to commercialise NaMuscla in EuropeExeltis Healthcare SL, Cresco Pharma BV and Macure Pharma ApS will commercialise NaMuscla for the symptomatic treatment of myotonia in adul...
New product launches will continue to drive growth: Glenn Saldanha, GlenmarkOur EBITDA margins continue to be about 17 plus per cent, says Glenmark Pharma CMD
Load More